SAVARA INC (SVRA:NASDAQ)

$4.52 0.3 (7.109%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 70

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SAVARA INC (SVRA:NASDAQ) News Sources

What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline

27-06-2026

fool.com

external link

Here's Why You Should Add Savara Stock to Your Portfolio Now

22-07-2026

yahoo.com

external link

Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041

30-07-2026

yahoo.com

external link

Savara Reports Second Quarter 2026 Financial Results and Provides Business Update

11-08-2026

yahoo.com

external link

Savara Announces New Employment Inducement Grant

20-08-2026

yahoo.com

external link

Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026

24-08-2026

yahoo.com

external link

Savara Has Lost 30% Since December: JPMorgan Sees 146% Upside

11-10-2026

tikr.com

external link

Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2026

12-10-2026

yahoo.com

external link

Will Long‑Term Molgramostim Data at CHEST 2026 Change Savara's (SVRA) Autoimmune PAP Narrative?

13-10-2026

yahoo.com

external link

Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment

21-10-2026

yahoo.com

external link

SAVARA INC (SVRA:NASDAQ) Sentiment Trend

0 25 50 75 100 93 93 69 81 71 61 9 76 67 79 27-06-2026 22-07-2026 30-07-2026 11-08-2026 20-08-2026 24-08-2026 11-10-2026 12-10-2026 13-10-2026 21-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SAVARA INC (SVRA:NASDAQ) FAQs

toggle

What is the current price of SAVARA INC (SVRA:NASDAQ)?

The current price of SAVARA INC (SVRA:NASDAQ) is $4.52.


toggle

SAVARA INC (SVRA:NASDAQ) absolute price change since previous trading day?

The absolute price change of SAVARA INC (SVRA:NASDAQ) since the previous trading day is $0.3.


toggle

SAVARA INC (SVRA:NASDAQ) percentage price change since previous trading day?

The percentage price change of SAVARA INC (SVRA:NASDAQ) since the previous trading day is 7.109%.


toggle

What is the most recent average sentiment score for SAVARA INC (SVRA:NASDAQ)?

The most recent average sentiment score for SAVARA INC (SVRA:NASDAQ) is 70 out of 100.


toggle

What is the most recent average sentiment for SAVARA INC (SVRA:NASDAQ)?

The most recent sentiment for SAVARA INC (SVRA:NASDAQ) is .


SEC-8K** Filing Available For SAVARA INC (SVRA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

SAVA (Cassava Sciences Inc)
SVCCU (Stellar V Capital Corp)
SVCC (Stellar V Capital Corp. Cl A)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.